{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:44:42Z","timestamp":1785588282667,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104197","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T02:20:13Z","timestamp":1664418013000},"page":"104197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR\/SOD2 cascade"],"prefix":"10.1016","volume":"68","author":[{"given":"Giulia","family":"Mallucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia Irene Maria","family":"Campagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foroogh","family":"Fahmideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7182-4272","authenticated-orcid":false,"given":"Alessia","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.104197_bib0001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2007.11.006","article-title":"PKC\u03b2II\/HuR\/VEGF: a new molecular cascade in retinal pericytes for the regulation of VEGF gene expression","volume":"57","author":"Amadio","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msard.2022.104197_bib0002","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0167-4781(90)90213-L","article-title":"Manganese superoxide dismutase: nucleotide and deduced amino acid sequence of a cDNA encoding a new human transcript","volume":"1087","author":"Church","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.msard.2022.104197_bib0003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lfs.2015.12.014","article-title":"Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes","volume":"145","author":"Emamgholipour","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.msard.2022.104197_bib0004","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032011","article-title":"Oral therapies for multiple sclerosis","volume":"9","author":"Faissner","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.msard.2022.104197_bib0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled Phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2022.104197_bib0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","article-title":"Superoxide radical and superoxide dismutases","volume":"64","author":"Fridovich","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.msard.2022.104197_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2015.04.006","article-title":"DMF, but not other fumarates, inhibits NF-\u03baB activity in vitro in an Nrf2-independent manner","volume":"283","author":"Gillard","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.104197_bib0008","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/1352458517703193","article-title":"No evident disease activity\u201d: the use of combined assessments in the management of patients with multiple sclerosis","volume":"23","author":"Giovannoni","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.104197_bib0009","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2022.104197_bib0010","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1073\/pnas.051627098","article-title":"Increased mitochondrial oxidative stress in the Sod2 (+\/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis","volume":"98","author":"Kokoszka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2022.104197_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","volume":"127\u2013128","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.msard.2022.104197_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2022.104197_bib0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00018-011-0810-7","article-title":"The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins","volume":"69","author":"Pascale","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.msard.2022.104197_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.msard.2022.104197_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102048","article-title":"Unraveling a new player in multiple sclerosis pathogenesis: the RNA-binding protein HuR","volume":"41","author":"Pistono","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.104197_bib0016","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.phrs.2017.03.025","article-title":"What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question","volume":"120","author":"Pistono","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msard.2022.104197_bib0017","doi-asserted-by":"crossref","first-page":"14636","DOI":"10.1096\/fj.201901930R","article-title":"Post-transcriptional regulation of Nrf2-mRNA by the mRNA-binding proteins HuR and AUF1","volume":"33","author":"Poganik","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.msard.2022.104197_bib0018","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.104197_bib0019","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/antiox9080700","article-title":"Exploring the use of dimethyl fumarate as microglia modulator for neurodegenerative diseases treatment","volume":"9","author":"Rosito","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.msard.2022.104197_bib0020","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104197_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2741\/3921","article-title":"HuR function in disease","volume":"17","author":"Srikantan","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.msard.2022.104197_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2016.02.010","article-title":"Role of dimethyl fumarate in oxidative stress of multiple sclerosis: a review","volume":"1019","author":"Suneetha","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.msard.2022.104197_bib0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bcpt.12581","article-title":"Protein Kinase C activation as a potential therapeutic strategy in Alzheimer's disease: is there a role for embryonic lethal abnormal vision-like proteins?","volume":"119","author":"Talman","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.msard.2022.104197_bib0024","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:12:08Z","timestamp":1761901928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822007027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S2211034822007027"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104197","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR\/SOD2 cascade","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104197"}}